Dr. Seyed Bagher Tabatabaei

MD, Phd, Board Certified Cardiology & Interventional Cardiology, Internal & Intensive Care Medicine

Interventional Cardiology

Work Experience

Dr. Tabatabaei has over 18 years of experience in the field of general and interventional cardiology with expertise in advanced diagnostic and therapeutic cardiovascular procedures. He has extensive experience in complex PCI, 24/7 cath lab procedures for STEMI, and critical cardiac care. He also specializes in cardiac device implantation including pacemakers, ICDs, CRT, and non-invasive diagnostics like TTE, TEE, and stress echocardiography.

Prior to joining Iranian Hospital Dubai as *Chief of the Cardiovascular Department* in 2013, Dr. Tabatabaei worked in Germany as Senior Attending Physician & Co-Director of the Cardiovascular Department at Erlenbach Hospital. He has also served as Attending Physician at University Hospital Red Crescent Frankfurt, Bad Soden Hospital Germany, and Ilanz Hospital Switzerland. He is a Visiting Professor in Tehran, Iran.

 Dr. Tabatabaei completed his Subspecialty in Cardiology & Interventional Cardiology at the University of Frankfurt, Germany and is Board Certified. He was a Fellow in Cardiovascular Intervention Research at Stanford University, California. He specialized in Internal & Intensive Care Medicine at the University of Bonn, Germany and obtained his Doctor of Medicine from the University of Frankfurt, with research in myocardial physiology.

Languages Spoken

• German
• English
• Farsi
• Arabic

Special Interests

• Complex PCI & 24/7 STEMI Management
• Cardiac Device Implantation: Pacemakers, ICD, CRT
• Non-Invasive Diagnostics: TTE, TEE, Stress Echo, Holter monitoring
• Critical Cardiac Care: CHF, Cardiogenic Shock, ICU/CCU management
• Intravascular Imaging: IVUS, OCT

Research / Publications

• Active in international cardiovascular research collaborations.
• Key research areas: L-Carnitine and fatty acids in Beta oxidation for CHF patients, Ultimate Stent Multicenter Registry, RIVER Study on Rivaroxaban efficacy in non-valvular AF, High specificity of CCTA for ischemic heart disease diagnosis, Correlation of Vitamin D deficiency with ACS incidence.